Europe Pharmaceutical Packaging Market Size (2024 - 2029)

The Europe Pharmaceutical Packaging Market is experiencing significant growth, driven by the expanding pharmaceutical industry and increasing healthcare spending. This market is adapting to challenges such as globalization, counterfeit threats, and the need for enhanced drug protection. Innovations in packaging technology, regulatory requirements for serialization and traceability, and a shift towards sustainable materials are key factors influencing the market's expansion. Despite facing challenges like stringent regulations and environmental concerns, the market continues to grow, supported by the demand for healthcare packaging and the integration of smart technologies.

Market Size of Europe Pharmaceutical Packaging Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
europe pharmaceutical packaging market size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR (2024 - 2029) 7.30 %
Market Concentration Medium

Major Players

europe pharmaceutical packaging market key players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Europe Pharmaceutical Packaging Market Analysis

The Europe Pharmaceutical Packaging Market is expected to register a CAGR of 7.30% during the forecast period.

The Europe Pharmaceutical Packaging Market is estimated to grow at a CAGR of about 7.3% over the forecast period 2021 to 2026. The pharmaceutical Industry industry in Europe is experiencing constant disruption as it experiences exponential growth with the changing lifestyle and more and more people being diagnosed with various diseases and increased spending on healthcare by the government bodies. However, it continues to face challenges such as globalization of drug supply, rise in chronic lifestyle, and evolving threat concerning counterfeit medicine, among others.

The pharmaceutical packaging industry in the region plays a vital role in helping the evolving pharma industry to address the impact associated with challenges being felt across the market, ensuring the protection of drugs against all sorts of alteration in the properties caused as a result of physical damage, degradation, biological contamination while driving boost in profits.

Over the period last few years, the packaging sector in the region has been experiencing a great deal of transformation with the industry-changing focus towards personalized approaches with development of platforms such as IoMT, genomics, and other connected medical devices, localized production of customized medicines added with the increase in the number of SMEs entering the market, increasing demand for cannabis-based medicinal products and diversification of the innovators.

Also, the introduction of innovative techniques like Blow-Fill-Seal technology and the increasing need for anti-counterfeiting technologies are changing the market drastically. The increasing globalization has resulted in the setting up of manufacturing plants all across the world, thereby improving the raw materials used and lengthening the supply chains.

Additionally, with the recent European Union (EU) regulations mandating pharmaceutical serialization is added with the US Drug Supply Chain Security Act, compliance extended to 2023 is driving the serialization and track-and-trace efforts, thereby are promoting pharmaceutical traceability and authenticity in the region. Similarly, other EU regulation now requires dimensional codes on the medical packaging to help identify the product and verify their authenticity; leveraging smartphone technology drives the digitalization of the packaging industry.

According to a study conducted by the UN, the release of antibodies into the environment will accelerate the emergence of resistant strains and will impact antibiotic pollution, which continues to be the topic of global discussion in 2020. Owing to such instances, the manufacturers of pharmaceutical packaging are showcasing greater emphasis on sustainability by considering recyclable and biodegradable packaging materials, reduction in their carbon footprint, and lifecycle analyses.

However, Europe has been the second, just behind North America with more than a third of the global market, but with the emergence of China and other Asia-Pacific nations remains a threat, the increasing need for faster production and enhanced shelf appeal are driving the market ahead. Some concerns to this market are the stringent regulations to pharmaceutical packaging by the governments across Europe, environmental concerns regarding the use of plastics, and the rising costs of raw materials used.

Before the global pandemic COVID-19, the industry was driving growth concerning the growth of the e-commerce industry, increased interest in sustainable materials, and integration of smart technologies. Still, later the pandemic, there has been a surge in demand for healthcare packaging such as pumps, flexible blister foils, among others. Also, with the need for biologics and vaccines, the companies are now investing in the sterile format and are expanding their production capacity.

Europe Pharmaceutical Packaging Industry Segmentation

The report provides a comprehensive analysis of the market segmented based on the packaging material used and the end-user industry. Detailed estimates for the next five years are included, along with the study of the major players and their strategies. Some of the major vendors are Amcor, CCL Industries, Intrapac, Rexam Plc, and Schott AG.

By Material Type
Plastic
Glass
Others Materials (Paper and Paperboard And Metal)
By Product Type
Bottles
Vials and Ampoules
Pouches
Syringes
Medication Tubes
Caps and Closures
Labels
Others Product Types
By Country
United Kingdom
Germany
France
Spain
Italy
Rest of Europe
Need A Different Region Or Segment?
Customize Now

Europe Pharmaceutical Packaging Market Size Summary

The European pharmaceutical packaging market is experiencing significant growth, driven by the evolving pharmaceutical industry and increasing healthcare expenditures. The market is adapting to challenges such as globalization, the rise of chronic diseases, and the threat of counterfeit medicines. Innovations in packaging technologies, like Blow-Fill-Seal and anti-counterfeiting measures, are transforming the industry. The focus is shifting towards personalized medicine, sustainability, and compliance with stringent regulations, such as those from the European Union and the US Drug Supply Chain Security Act. These regulations are promoting traceability and authenticity in pharmaceutical products, while also encouraging the use of recyclable and biodegradable materials to reduce environmental impact.

Germany plays a pivotal role in the European pharmaceutical packaging market, with significant contributions from major companies like Gerresheimer AG and Schott AG. The region's market is moderately fragmented, with key players investing in sustainability and digitization initiatives. Partnerships and expansions, such as those by Amcor and Schott AG, are enhancing the market's capacity and innovation. The demand for sustainable and high-quality packaging solutions is driving investments and collaborations, aiming to meet the growing needs of the pharmaceutical and medical device industries. As the market continues to evolve, the emphasis on safety, sustainability, and advanced healthcare infrastructure is expected to further boost growth.

Explore More

Europe Pharmaceutical Packaging Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growth in Pharmaceutical industries in Emerging economies

      2. 1.2.2 Growing demand for drug delivery devices & Blister packaging market

      3. 1.2.3 Contribution of Nano-technology in the growth of Europe Pharmaceutical packaging

      4. 1.2.4 Growth in over-the-counter market

      5. 1.2.5 Developing interest in sustainable packaging materials, and integration of smart technologies

    3. 1.3 Market Restraints

      1. 1.3.1 Increaing Packaging costs

      2. 1.3.2 Stricter health regulatory compliance standards, Environmental concerns

    4. 1.4 Value Chain / Supply Chain Analysis

    5. 1.5 Porter's Five Forces Analysis

      1. 1.5.1 Threat of New Entrants

      2. 1.5.2 Bargaining Power of Buyers

      3. 1.5.3 Bargaining Power of Suppliers

      4. 1.5.4 Threat of Substitute Products

      5. 1.5.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Material Type

      1. 2.1.1 Plastic

      2. 2.1.2 Glass

      3. 2.1.3 Others Materials (Paper and Paperboard And Metal)

    2. 2.2 By Product Type

      1. 2.2.1 Bottles

      2. 2.2.2 Vials and Ampoules

      3. 2.2.3 Pouches

      4. 2.2.4 Syringes

      5. 2.2.5 Medication Tubes

      6. 2.2.6 Caps and Closures

      7. 2.2.7 Labels

      8. 2.2.8 Others Product Types

    3. 2.3 By Country

      1. 2.3.1 United Kingdom

      2. 2.3.2 Germany

      3. 2.3.3 France

      4. 2.3.4 Spain

      5. 2.3.5 Italy

      6. 2.3.6 Rest of Europe

Europe Pharmaceutical Packaging Market Size FAQs

The Europe Pharmaceutical Packaging Market is projected to register a CAGR of 7.30% during the forecast period (2024-2029)

Amcor Ltd., CCL Industries Inc., Intrapac Group, Schott AG and Gerresheimer AG are the major companies operating in the Europe Pharmaceutical Packaging Market.

Europe Pharmaceutical Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)